{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:54:59Z","timestamp":1753890899526,"version":"3.41.2"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T00:00:00Z","timestamp":1722902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p>Hypertrophic cardiomyopathy (HCM) is caused by myocardial hypertrophy, often due to mutations in cardiac sarcomere protein genes such as beta-myosin heavy chain (MYH7) and myosin-binding protein C (MYBPC3). However, a significant proportion of HCM cases lack identified genetic mutations, and genotype-phenotype correlations remain unclear. Concurrently, potential associations between HCM and human leukocyte antigen (HLA) types, as well as connective tissue diseases, have been proposed. In this single-center study, we aimed to investigate the genetic and HLA profiles of patients with obstructive hypertrophic cardiomyopathy (HOCM) and connective tissue diseases, particularly focusing on the prevalence of genetic variants and HLA types. We conducted a detailed analysis of five patients with HOCM and connective tissue diseases and sarcoidosis, identifying rare variants in causative genes for HCM in two cases and observing specific HLA types that were relatively common. Notably, 15% of all HOCM cases presented with connective tissue diseases, mainly rheumatoid arthritis. These findings underscore the complexity of HCM etiology and suggest potential implications for both diagnostic strategies and therapeutic approaches in patients with concomitant inflammatory conditions. <\/jats:p>","DOI":"10.3389\/fgene.2024.1432670","type":"journal-article","created":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T04:30:43Z","timestamp":1722918643000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Genetic testing and human leukocyte antigen in patients with hypertrophic cardiomyopathy and connective tissue diseases"],"prefix":"10.3389","volume":"15","author":[{"given":"Daigo","family":"Hiraya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Murakoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miyako","family":"Igarashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DongZhu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Ishizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,8,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task Force for the diagnosis and management of hypertrophic cardiomyopathy of the European society of cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur. Heart J."},{"key":"B2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.12667\/mhc.28.83","article-title":"Overview of HLA DNA typing technology","volume":"28","author":"Azuma","year":"2021","journal-title":"Major Histocompat. Complex"},{"key":"B3","doi-asserted-by":"publisher","first-page":"10401","DOI":"10.3390\/ijms221910401","article-title":"Genetic testing in patients with hypertrophic cardiomyopathy","volume":"22","author":"Bonaventura","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1093\/bioinformatics\/btaa684","article-title":"HATK: HLA analysis toolkit","volume":"37","author":"Choi","year":"2021","journal-title":"Bioinformatics"},{"key":"B5","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.ahj.2013.07.010","article-title":"Rheumatoid arthritis and cardiovascular disease","volume":"166","author":"Crowson","year":"2013","journal-title":"Am. Heart J."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e2028","DOI":"10.7759\/cureus.2028","article-title":"Association of hypertrophic obstructive cardiomyopathy with rheumatoid arthritis","volume":"10","author":"Dawood","year":"2018","journal-title":"Cureus"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1161\/CIRCULATIONAHA.108.827618","article-title":"Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells","volume":"119","author":"Eid","year":"2009","journal-title":"Circulation"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1012661","DOI":"10.3389\/fcvm.2022.1012661","article-title":"Disease-modifying anti-rheumatic drugs improve the cardiovascular profile in patients with rheumatoid arthritis","volume":"9","author":"Giachi","year":"2022","journal-title":"Front. Cardiovasc Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s00251-005-0048-3","article-title":"High-throughput DNA typing of HLA-A, -B, -C, and -DRB1 loci by a PCR-SSOP-Luminex method in the Japanese population","volume":"57","author":"Itoh","year":"2005","journal-title":"Immunogenetics"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1253\/circj.CJ-20-0910","article-title":"JCS\/JHFS 2018 guideline on the diagnosis and treatment of cardiomyopathies","volume":"85","author":"Kitaoka","year":"2021","journal-title":"Circ. J."},{"key":"B11","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1161\/CIRCRESAHA.117.311059","article-title":"Hypertrophic cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy","volume":"121","author":"Marian","year":"2017","journal-title":"Circ. Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1056\/NEJMra1710575","article-title":"Clinical course and management of hypertrophic cardiomyopathy","volume":"379","author":"Maron","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/nejmra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"Mclnnes","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1007\/s00296-008-0608-6","article-title":"A case of mixed connective tissue disease complicated with hypertrophic obstructive cardiomyopathy","volume":"28","author":"Nakamura","year":"2008","journal-title":"Rheumatol. Int."},{"key":"B15","doi-asserted-by":"publisher","first-page":"115","DOI":"10.12667\/mhc.23.115","article-title":"Basic knowledge 1 of HLA","volume":"23","author":"Ogawa","year":"","journal-title":"Major Histocompat. Complex"},{"key":"B16","doi-asserted-by":"publisher","first-page":"185","DOI":"10.12667\/mhc.23.185","article-title":"Basic knowledge of HLA part 2","volume":"23","author":"Ogawa","year":"","journal-title":"Major Histocompat. Complex"},{"key":"B17","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/s0167-5273(97)00256-8","article-title":"Hypertrophic obstructive cardiomyopathy due to a novel T-to-A transition at codon 624 in the beta-myosin heavy chain (beta-MHC) gene possibly related to the sudden death","volume":"62","author":"Ohsuzu","year":"1997","journal-title":"Int. J. Cardiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/ar91","article-title":"Association of MHC and rheumatoid arthritis. Association of RA with HLA-DR4: the role of repertoire selection","volume":"2","author":"Roudier","year":"2000","journal-title":"Arthritis Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"3520","DOI":"10.1172\/JCI42028","article-title":"Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-\u03b2","volume":"120","author":"Teekakirikul","year":"2010","journal-title":"J. Clin. Invest."},{"key":"B20","doi-asserted-by":"publisher","first-page":"87","DOI":"10.12667\/mhc.21.87","article-title":"Applications of HLA gene polymorphisms","volume":"21","author":"Tokunaga","year":"2014","journal-title":"Major Histocompat. Complex"},{"key":"B21","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.jjcc.2022.09.012","article-title":"Additional diagnostic value of electron microscopic examination in endomyocardial biopsy in patients with suspected non-ischemic cardiomyopathy","volume":"81","author":"Yamamoto","year":"2023","journal-title":"J. Cardiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3109\/14397595.2013.854059","article-title":"Estimates of the prevalence of and current treatment practices for rheumatoid arthritis in Japan using reimbursement data from health insurance societies and the IORRA cohort (I)","volume":"24","author":"Yamanaka","year":"2014","journal-title":"Mod. Rheumatol."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2024.1432670\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T04:30:45Z","timestamp":1722918645000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2024.1432670\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,6]]},"references-count":22,"alternative-id":["10.3389\/fgene.2024.1432670"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2024.1432670","relation":{},"ISSN":["1664-8021"],"issn-type":[{"type":"electronic","value":"1664-8021"}],"subject":[],"published":{"date-parts":[[2024,8,6]]},"article-number":"1432670"}}